End­points Man­u­fac­tur­ing: 5 Ques­tions with Ho­mol­o­gy Med­i­cines

This week, I asked five ques­tions of Tim Kel­ly, the chief tech­nol­o­gy of­fi­cer at Ho­mol­o­gy Med­i­cines. Kel­ly has over two decades of ex­pe­ri­ence in man­u­fac­tur­ing, hav­ing spent time at Sarep­ta and Shire be­fore join­ing Ho­mol­o­gy.

The Bed­ford, MA com­pa­ny is seek­ing to har­ness a nov­el tech­nol­o­gy that us­es AAV vec­tors de­rived from hu­man hematopoi­et­ic stem cells that are de­signed to pre­cise­ly and ef­fi­cient­ly de­liv­er ge­net­ic med­i­cines in­to the hu­man body. Part of Kel­ly’s tenure has in­clud­ed con­struc­tion of the com­pa­ny’s in-house man­u­fac­tur­ing fa­cil­i­ty.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER